title: Roxithromycin in the eradication of Helicobacter pylori.
authors.forename: K L
authors.initials: KL
authors.lastname: Goh
authors.forename: S Y
authors.initials: SY
authors.lastname: Chuah
authors.forename: M
authors.initials: M
authors.lastname: Azian
authors.forename: N
authors.initials: N
authors.lastname: Parasakthi
authors.forename: S C
authors.initials: SC
authors.lastname: Peh
authors.forename: N W
authors.initials: NW
authors.lastname: Wong
authors.forename: Y L
authors.initials: YL
authors.lastname: Lo
authors.forename: K K
authors.initials: KK
authors.lastname: Ong
mesh_terms: D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D015575:Roxithromycin / Q000627:therapeutic use*
chemical_list: D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D009942:Organometallic Compounds; D010880:Piperidines; D015575:Roxithromycin; C002791:bismuth tripotassium dicitrate; D009853:Omeprazole; D001729:Bismuth; C053742:roxatidine acetate